Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Carcinoma Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00003525
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Who this might be right for
Cervical Cancer Stage IVVulvar Cancer, Stage IV
Burzynski Research Institute 8
Not applicableNot Yet RecruitingNCT06062589
What this trial is testing

AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Peking University Third Hospital 18
Large-scale testing (Phase 3)UnknownNCT05715840
What this trial is testing

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

Who this might be right for
Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 368
Testing effectiveness (Phase 2)Ended earlyNCT03108495
What this trial is testing

Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
Iovance Biotherapeutics, Inc. 210
Large-scale testing (Phase 3)UnknownNCT00532818
What this trial is testing

Hydralazine Valproate for Cervical Cancer

Who this might be right for
Metastatic Cervical Cancer
National Institute of Cancerología 143
Testing effectiveness (Phase 2)Ended earlyNCT03894215
What this trial is testing

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Who this might be right for
Cervical Cancer
Agenus Inc. 211
Not applicableNot Yet RecruitingNCT06649838
What this trial is testing

Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions

Who this might be right for
ImmunotherapyCervical CancerCtDNA+1 more
Peking Union Medical College Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00309959
What this trial is testing

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+2 more
Gynecologic Oncology Group 37
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT04680988
What this trial is testing

SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd. 194
Testing effectiveness (Phase 2)UnknownNCT05051696
What this trial is testing

Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

Who this might be right for
Genital Neoplasms, Female
Liu Zi 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Not applicableWithdrawnNCT01313104
What this trial is testing

Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 1Cervical Intraepithelial Neoplasia Grade 2Cervical Intraepithelial Neoplasia Grade 3+22 more
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT01026792
What this trial is testing

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00057863
What this trial is testing

Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00003065
What this trial is testing

Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix

Who this might be right for
Cervical Cancer
Herbert Irving Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07763496
What this trial is testing

Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
ARCAGY/ GINECO GROUP 63
Testing effectiveness (Phase 2)UnknownNCT04395612
What this trial is testing

Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 38
Next Page